Roivant Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Roivant Sciences (ROIV).

Price Target Range — 12 Quarters

Analyst Consensus — 15 Analysts

14Buy

1Hold

Consensus RatingBuy# Analysts15Avg. Consensus PT$34Upside to Avg. PT-5.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 17, 2026	Stifel	Alex Thompson	Initiate	Buy	$51
Sep 9, 2026	TD Cowen	Yaron Werber	PT Raise	Buy	$50→$55
Sep 9, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$42→$46
Sep 8, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$41→$47
Sep 8, 2026	Jefferies	Dennis Ding	PT Raise	Buy	$42→$52
Aug 28, 2026	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$41
Aug 10, 2026	Citigroup	Samantha Semenkow	PT Raise	Buy	$42→$46
Aug 7, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$36→$42
Aug 7, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$34→$41
May 26, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$30→$36
May 21, 2026	Citigroup	Samantha Semenkow	PT Raise	Buy	$35→$42
May 21, 2026	TD Cowen	Yaron Werber	PT Raise	Buy	$38→$41
May 21, 2026	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$34
Apr 16, 2026	Piper Sandler	Yasmeen Rahimi	PT Raise	Overweight	$22→$40
Mar 4, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$33→$34
Feb 10, 2026	Citigroup	Samantha Semenkow	PT Raise	Buy	$26→$35
Feb 10, 2026	HC Wainwright & Co.	Douglas Tsao	PT Raise	Buy	$26→$33
Feb 9, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$28→$30
Dec 15, 2025	Leerink Partners	David Risinger	PT Raise	Outperform	$29→$32
Dec 15, 2025	Goldman Sachs	Corinne Jenkins	PT Raise	Buy	$24→$33

More with Benzinga EdgeGet Access

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Buy ratings for MNOV ($6), IBIO ($7), ROIV ($51), and PAY ($42); FHN rated Market Perform at $25.

Avi Kapoor

PRO
Stifel Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $51

Stifel analyst Alex Thompson initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Price Target of $51.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Roivant Sciences, Raises Price Target to $55

TD Cowen analyst Yaron Werber maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $50 to $55.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $46

Guggenheim analyst Yatin Suneja maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $42 to $46.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $41 to $47.

Benzinga Newsdesk

PRO
Jefferies Maintains Buy on Roivant Sciences, Raises Price Target to $52

Jefferies analyst Dennis Ding maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $42 to $52.

Benzinga Newsdesk

Roivant Sciences Ltd

Roivant Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
Stifel Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $51

PRO
TD Cowen Maintains Buy on Roivant Sciences, Raises Price Target to $55

PRO
Guggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $46

PRO
HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47

PRO
Jefferies Maintains Buy on Roivant Sciences, Raises Price Target to $52

People Also Watch

People Also Watch

Roivant Sciences Ltd

Roivant Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PROStifel Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $51

PROTD Cowen Maintains Buy on Roivant Sciences, Raises Price Target to $55

PROGuggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $46

PROHC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47

PROJefferies Maintains Buy on Roivant Sciences, Raises Price Target to $52

People Also Watch

People Also Watch

PRO
Stifel Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $51

PRO
TD Cowen Maintains Buy on Roivant Sciences, Raises Price Target to $55

PRO
Guggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $46

PRO
HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47

PRO
Jefferies Maintains Buy on Roivant Sciences, Raises Price Target to $52